After surgery, microscopic cancer cells are still left behind in the body. As an “insurance policy” patients are told by their oncologists to undergo chemotherapy or radiotherapy (or both). The idea is to kill whatever cancer cells are left behind. But how effective is this? How valid is the assumption that chemotherapy can just do that?
I invite you to read the following research papers and give them some serious thought. Form your own opinion as to what you would want to do in the event that you suffer from early stage (Stage 2) colorectal cancer.
Scholefield J.H. in an article: “Challenges in colorectal cancer.” (Book review. New England J of Medicine. September 2000. Vol: 343:893.) Wrote:
“Colorectal cancer presents some of the most challenging problems for basic scientists, clinical investigators and practitioners. Surgery remains the centre of attention.”
Question: All these years, why is the treatment of colorectal “most challenging?” Has the treatment protocol for colorectal cancer not been worked out yet?
Moertel, C. G. (in Chemotherapy for colorectal cancer. New England J. of Medicine. April 1994. Vol: 330: 1136-1142) wrote:
“Radiation therapy plays only a palliative role. In the past, chemotherapy resulted in only infrequent and usually transient shrinkage of the tumor. Its use is scarcely justified in view of the discomforts and costs of the treatment. However, now there have been some advances.” Continue Reading
